Concepedia

Andrei Leonov

AL

Statistics

Publications

44

Citations

2.7K

H-Index

31

Active since

2000

Affiliations

Max Planck Institute for Biophysical Chemistry(Current)

Ludwig-Maximilians-Universität München

University of Göttingen

Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103

German Center for Neurodegenerative Diseases

Andrei Leonov is an author at Max Planck Institute for Biophysical Chemistry specializing in life sciences, neuroscience, and neurodegeneration.

ORCID

Publications per year

2000–2023

44

Publications

44

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease

Jens A. Wagner, Sergey Ryazanov, Andrei Leonov et al. · Acta Neuropathologica · 2013 · 456 citations · Full text

, , +17

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model

Michał Węgrzynowicz, Dana Bar-On, Laura Calò et al. · Acta Neuropathologica · 2019 · 126 citations · Full text

, , +17

Stereochemistry of Sagittamide A from Residual Dipolar Coupling Enhanced NMR

Anne Schuetz, J. Junker, Andrei Leonov et al. · Journal of the American Chemical Society · 2007 · 118 citations · Full text

, , +13

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy

Antonio Heras‐Garvin, Daniel Weckbecker, Sergey Ryazanov et al. · Movement Disorders · 2018 · 115 citations · Full text

, , +17

Cardiolipin Promotes Pore-Forming Activity of Alpha-Synuclein Oligomers in Mitochondrial Membranes

Stephanie Ghio, Angelique Camilleri, Mario Caruana et al. · ACS Chemical Neuroscience · 2019 · 109 citations

, , +17

1–5 of 44